Abstract
As a group, we met to discuss the current challenges for creating meaningful patient-specific in vitro models to study brain disorders. Although the convergence of findings between laboratories and patient cohorts provided us confidence and optimism that hiPSC-based platforms will inform future drug discovery efforts, a number of critical technical challenges remain. This opinion piece outlines our collective views on the current state of hiPSC-based disease modeling and discusses what we see to be the critical objectives that must be addressed collectively as a field.
Original language | English (US) |
---|---|
Pages (from-to) | 933-945 |
Number of pages | 13 |
Journal | Stem Cell Reports |
Volume | 5 |
Issue number | 6 |
DOIs | |
State | Published - Dec 8 2015 |
ASJC Scopus subject areas
- Biochemistry
- Genetics
- Developmental Biology
- Cell Biology